Prelude Therapeutics Stock (NASDAQ: PRLD) stock price, news, charts, stock research, profile.
You can purchase shares of Prelude Therapeutics (NASDAQ:PRLD) through any online brokerage.
Other companies in Prelude Therapeutics’s space includes: Serina Therapeutics (AMEX:SER), Fortress Biotech (NASDAQ:FBIO), Kezar Life Sciences (NASDAQ:KZR), Gain Therapeutics (NASDAQ:GANX) and Connect Biopharma Hldgs (NASDAQ:CNTB).
Prelude Therapeutics has a consensus price target of $5.50.
The stock price for Prelude Therapeutics (NASDAQ: PRLD) is $1.2794 last updated December 20, 2024 at 7:56 PM EST.
There are no upcoming dividends for Prelude Therapeutics.
Prelude Therapeutics’s Q4 earnings are confirmed for Thursday, February 13, 2025.
There is no upcoming split for Prelude Therapeutics.
Prelude Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.